CD6 is a therapeutic target for LN
- PMID: 35136210
- DOI: 10.1038/s41584-022-00756-w
CD6 is a therapeutic target for LN
Comment on
-
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.J Clin Invest. 2022 Jan 4;132(1):e147334. doi: 10.1172/JCI147334. J Clin Invest. 2022. PMID: 34981775 Free PMC article.
References
Original article
-
- Chalmers, S. A. et al. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. J. Clin. Invest. 132, e147334 (2022) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous